Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70

United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$4.14M

$915.82K on a plan · $3.12M straight out of an exercise

Sold at will

$100.28K

1 of 10 sales

Net

−$4.14M

−$100.28K against sales at will